Selleck Chemicals - Model A2543 -Tinurilimab (Anti-CEACAM6 / CD66c)

Tinurilimab (Anti-CEACAM6 / CD66c) is an monoclonal antibody targeting against CEACAM6 and CD66c. CEACAM6 is an immune checkpoint regulator suppressing the activity of effector T-cells against tumors. MW: 145.5 KD.